Physician
Hoover Urgent Care of Warren PLLC
Hoover Urgent Care of Warren PLLC was paid $11.69M by Medicaid between Jan 2018 and Dec 2024, across 79 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoHOOVER URGENT CARE OF WARREN PLLC
WARREN, MI 48089
WARREN, MI 48089
33aNPI1821351610assigned 06/18/2012
33bProvider typeFamily Medicine Physician
28Total paid$11.69M
24GClaims375,163
24DCodes billed79
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Michigan
Rank by total paid#12 of 826
Median peer was paid$98K
This provider vs. median120×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,943 | $735K | |
| 2019 | 28,625 | $862K | |
| 2020 | 27,034 | $881K | |
| 2021 | 61,638 | $2.03M | |
| 2022 | 99,412 | $2.98M | |
| 2023 | 71,782 | $2.17M | |
| 2024incomplete | 62,729 | $2.02M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 73,325 | 66,748 | $3.76M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 36,372 | 34,149 | $2.44M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 17% | 32,383 | 32,127 | $2.02M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.7% | 36,296 | 33,786 | $1.02M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.4% | 6,974 | 6,920 | $626K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.8% | 26,382 | 13,382 | $322K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 6,100 | 5,841 | $232K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 17,889 | 17,358 | $201K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.6% | 3,791 | 3,778 | $185K |
| 99058 | 1.3% | 2,599 | 2,110 | $148K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 14,116 | 13,365 | $114K |
| 81025 | <1% | 19,120 | 18,193 | $110K |
67 more codes
| 99000 | <1% | 29,513 | $73K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,455 | $66K |
| 81002 | <1% | 25,601 | $62K | |
| 73130 | <1% | 1,901 | $35K | |
| 73630 | <1% | 1,505 | $26K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 204 | $20K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,407 | $20K |
| 73610 | <1% | 950 | $19K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,898 | $15K |
| 73562 | <1% | 596 | $13K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 2,494 | $13K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 320 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,013 | $10K |
| 69210 | <1% | 332 | $9K | |
| 16020 | <1% | 219 | $9K | |
| 90715 | <1% | 344 | $9K | |
| 73110 | <1% | 358 | $8K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 375 | $8K |
| 93000 | <1% | 989 | $8K | |
| 73030 | <1% | 299 | $6K | |
| 10060 | <1% | 97 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 517 | $5K |
| 72100 | <1% | 243 | $5K | |
| 87807 | <1% | 502 | $4K | |
| 99459 | <1% | 278 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,931 | $4K |
| 99205 | Prolong outpt/office vis | <1% | 25 | $3K |
| 12001 | <1% | 54 | $3K | |
| 29540 | <1% | 176 | $3K | |
| 82962 | <1% | 1,002 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,018 | $2K |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 216 | $2K |
| 29130 | <1% | 72 | $2K | |
| 90714 | <1% | 95 | $2K | |
| 73560 | <1% | 80 | $2K | |
| 72040 | <1% | 54 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 191 | $951.04 |
| 74240 | <1% | 12 | $896.16 | |
| 73120 | <1% | 47 | $852.08 | |
| 86308 | <1% | 163 | $837.76 | |
| 99406 | <1% | 155 | $800.36 | |
| 74019 | <1% | 33 | $734.47 | |
| 74241 | <1% | 28 | $720.00 | |
| 29530 | <1% | 38 | $689.62 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 514 | $673.84 |
| 73620 | <1% | 27 | $487.64 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 1,985 | $331.24 |
| 74018 | <1% | 18 | $320.94 | |
| 73600 | <1% | 13 | $228.24 | |
| 29260 | <1% | 14 | $226.59 | |
| 86328 | <1% | 18 | $189.80 | |
| 29280 | <1% | 12 | $172.11 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 113 | $134.70 |
| 36410 | <1% | 1,128 | $105.31 | |
| 99401 | <1% | 19 | $95.00 | |
| 99001 | <1% | 1,127 | $90.16 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 189 | $84.96 |
| 87301 | <1% | 15 | $52.72 | |
| 99072 | <1% | 625 | $36.00 | |
| A6451 | Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard | <1% | 194 | $28.95 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 34 | $6.13 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 52 | $4.12 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 431 | $0.00 |
| 99050 | 0% | 51 | $0.00 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | 0% | 306 | $0.00 |
| G9498 | Antibiotic regimen prescribed | 0% | 20 | $0.00 |
| 99051 | 0% | 1,111 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAMMOUD, NIDAL (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Get Well Urgent Care Downriver PLC | Lincoln Park, MI | $6.18M |
| Nidal Hammoud DDS. PLLC | Dearborn, MI | $4.95M |
| Oak Park Urgent Care PLLC | Oak Park, MI | $4.88M |
| Get Well Urgent Care Madison Heights PLC | Madison Heights, MI | $4.74M |
| Get Well Urgent Care Harper Woods PLC | Harper Woods, MI | $1.51M |
| Get Well Urgent Care Southgate PLC | Southgate, MI | $1.39M |
| Get Well Urgent Care Detroit, PLC | Detroit, MI | $526K |
| Get Well Urgent Care Macomb PLC | Clinton Twp, MI | $480K |
| Get Well Urgent Care Pontiac PLC | Pontiac, MI | $346K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.